Sify reports Consolidated Financial Results for Q2 FY 2024-25
October 22, 2024 07:39 ET
|
Sify Technologies Limited
Revenues of INR 10275 Million. EBITDA of INR 1963 Million. Profit for the period INR 49 Million. CHENNAI, India, Oct. 22, 2024 (GLOBE NEWSWIRE) -- EARNINGS CALL DETAILS October, 22, 2024 |...
MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11
September 09, 2024 07:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a clinical-stage...
GDEV announces unaudited results for the second quarter and first half of 2024
September 04, 2024 08:00 ET
|
GDEV Inc.
GDEV announces unaudited results for the second quarter and first half of 2024
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
August 14, 2024 07:00 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...
Rumble Reports Second Quarter 2024 Results
August 12, 2024 16:05 ET
|
Rumble, Inc.
~ Delivers Sequential Revenue Growth of 27% to $22.5 Million ~ ~ Introduces New KPI, Average Revenue Per User (ARPU), Up 19% Over First Quarter ~ LONGBOAT KEY, Fla., Aug. 12, 2024 (GLOBE...
Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14
August 12, 2024 07:27 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Nova Leap Health Corp. Posts Q2 2024 Results that include a Continuation of Strong Operating Results, a Strong Balance Sheet and the Re-engagement of M&A
August 08, 2024 17:00 ET
|
Nova Leap Health Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 08, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or...
SYLOGIST Reports Second Quarter 2024 Results
August 08, 2024 06:00 ET
|
Sylogist Ltd.
SYLOGIST Reports Second Quarter 2024 Results
Sezzle Reports Second Quarter 2024 Results
August 07, 2024 15:59 ET
|
Sezzle
Minneapolis, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, is pleased to update the market on key financial...
MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11
August 07, 2024 08:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3 VELA program of the Nanobody® sonelokimab in...